Apelin Receptor (APLNR) Peptid
APLNR
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN940165
382,12 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für Apelin Receptor (APLNR) Peptid (ABIN940165)
Target
Apelin Receptor (APLNR)
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- LAKLKKKKGP STVTDLEDTK RDRSVDVNGG PEPAPASTSA VSTPSPSADL
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of APLNR antibody,
Alternative Names: APLNR control peptide, APLNR antibody Blocking Peptide, Anti-APLNR Blocking Peptide, apelin receptor Blocking Peptide, AGTRL1 Blocking Peptide, APJ Blocking Peptide, APJR Blocking Peptide, FLJ90771 Blocking Peptide, FLJ96609 Blocking Peptide, HG11 Blocking Peptide, MGC45246 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- Apelin Receptor (APLNR)
-
Hintergrund
- This gene encodes a member of the G protein-coupled receptor gene family. The encoded protein is related to the angiotensin receptor, but is actually an apelin receptor that inhibits adenylate cyclase activity and plays a counter-regulatory role against the pressure action of angiotensin II by exerting hypertensive effect. It functions in the cardiovascular and central nervous systems, in glucose metabolism, in embryonic and tumor angiogenesis and as a human immunodeficiency virus (HIV-1) coreceptor. Two transcript variants resulting from alternative splicing have been identified.
-
Molekulargewicht
- 104 kDa
Target
-
Sie sind hier:
